Navigation Links
The American Society for Microbiology honors Alison Criss
Date:9/13/2011

Alison K. Criss, Ph.D., University of Virginia, Charlottesville, has been chosen by the American Society for Microbiology (ASM) to receive a 2011 ICAAC Young Investigator Award for her outstanding research on bacterial pathogenesis. Sponsored by Merck, U.S. Human Health Division, this award recognizes an early career scientist for research excellence in microbiology and infectious diseases.

Dr. Criss received her Ph.D. from Harvard University and completed her postdoctoral fellowship at Northwestern University. She was nominated by her postdoctoral advisor, H. Steven Seifert, Fellow of the American Academy of Microbiology, who describes Dr. Criss as an "extremely intelligent, insightful, diligent, meticulous, hard working person who tackles problems head-on."

Dr. Criss is currently an Assistant Professor in the Department of Microbiology at the University of Virginia, where she studies the interactions of Neisseria gonorrhoeae with PMNs in her laboratory at the University of Virginia. A supporter of her nomination, Joanna Goldberg, Academy Fellow from the University of Virginia, describes Dr. Criss as "truly a rising young star [who] has a very professional and enthusiastic manner that serves to engage and inspire students to perform at the best of their ability."

Dr. Criss' research focuses on the interplay between bacterial pathogens and host cells at mucosal surfaces. Her graduate work explored the regulation of Salmonella pathogenesis by Rho and ARF family GTPases in polarized epithelial cells. As a postdoctoral fellow at Northwestern, Dr. Criss investigated the robust mechanisms by which N. gonorrhoeae avoids immune recognition and clearance. N. gonorrhoeae evades humoral immunity by varying its surface components, including antigenic variation of the type IV pilus. She used high-throughput DNA sequencing to show that pilin antigenic variation occurs at the highest frequency of any known pathogenic gene conversion system and produces a diverse repertoire of pilin proteins, as observed during human disease. N. gonorrhoeae also survives exposure to neutrophils in gonorrheal secretions, for reasons that are poorly understood. Using a primary human neutrophil infection model, Dr. Criss demonstrated that N. gonorrhoeae suppresses neutrophil production of reactive oxidative species and encodes gene products that confer resistance to neutrophils' non-oxidative antimicrobial activities. Her laboratory at the University of Virginia is elucidating the molecular and cellular interactions between N. gonorrhoeae and neutrophils, with the goals of identifying the antimicrobial activities neutrophils direct against N. gonorrhoeae and the bacterial defenses that subvert them.

William Shafer, Academy Fellow from Emory University and supporter of Dr. Criss' nomination, says "I have been most favorably impressed by the rigor that Dr. Criss applies to her work, the depth of her thought processes, and her willingness to freely exchange ideas and reagents She has performed the most convincing (and elegant) work to date that shows N. gonorrhoeae can resist intraleukocytic killing by human PMNs."


'/>"/>

Contact: Garth Hogan
ghogan@asmusa.org
American Society for Microbiology
Source:Eurekalert

Related biology news :

1. News from the October 2008 Journal of the American Dietetic Association
2. American Chemical Societys Weekly PressPac -- Sept. 24, 2008
3. Nanotech and synbio: Americans dont know whats coming
4. American Chemical Societys Weekly PressPac
5. American College of Medical Genetics receives $13.5M NIH contract
6. The American Society of Human Genetics hosts 58th Annual Meeting in Philadelphia
7. American Chemical Society Weekly PressPac Oct. 15, 2008
8. Scientists map soils on an extinct American volcano
9. Indiana University research at American Public Health Association meeting
10. North American environmental commission launches trinational vaquita conservation plan
11. News from the November 2008 Journal of the American Dietetic Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2016)... Feb. 2, 2016 Checkpoint Inhibitors for ... Market Are you interested in the future ... for checkpoint inhibitors. Visiongain,s report gives those predictions ... and national level. Avoid falling behind in ... opportunities and revenues those emerging cancer therapies can ...
(Date:2/1/2016)... -- Today, the first day of American Heart Month, the ... first of its kind workplace health solution that leverages ... first application of Watson to ... Welltok will create a new offering that combines AHA,s ... on Welltok,s health optimization platform. The effort is intended ...
(Date:1/25/2016)... , Jan. 25, 2016  Glencoe Software, the ... pharma and publication industries, will provide the data management ... Centre (NPSC). ... Phenotypic analysis measures ... whole organisms, allowing comparisons between states such as health ...
Breaking Biology News(10 mins):
(Date:2/10/2016)... , ... February 10, 2016 , ... ... the International Society of Pharmaceutical Engineering (ISPE) Rocky Mountain Chapter 21st Annual Vendor ... expecting to fill more than 100 tables for its annual event, which will ...
(Date:2/10/2016)... ... February 10, 2016 , ... PatientCrossroads announces ... the secure online PatientCrossroads platform, has exceeded both its one-year and overall recruitment ... PROMPT study, which seeks to advance understanding of the hereditary risks for certain ...
(Date:2/10/2016)... ... February 10, 2016 , ... Cenna Bioscience Inc., an ... treatment of Alzheimer’s disease, announced today it has been selected to present at the ... Breakers in Palm Beach, Florida. The purpose of the Forum is to help ...
(Date:2/9/2016)... 9, 2016  Regenicin, Inc. (OTC Bulletin Board: ... the development and commercialization of regenerative cell therapies ... organs, recently reported the Company,s operating results for ... 2016. Lonza America , Inc. (the ... year in the process of consummating an agreement ...
Breaking Biology Technology: